Philippe Danjou

Biography

Philippe Danjou, is an MD with training in Clinical Pharmacology and Pain Management, and has over 30 years of academic and industry experience in clinical research. He has joined Biotrial in 2012 as Senior Director R & D with extensive knowledge in pain and neuropsychopharmacology acquired in France (Pitié Salpétrière) and at the New York Psychiatric Institute. Prior to this, he held positions as Head of Clinical Pharmacology in several pharmaceutical groups for 19 years has held several positions as Worldwide Clinical Pharmacologist for Synthélabo, Head of European Early Development Group for Wyeth, Head of Early Development for Sanofi and Head of CNS Early Development for Merck Sharpe & Dohme. Dr. Danjou has a PhD in Clinical and Experimental Pharmacology and is board certified for the advanced treatment of pain.

Research Interest

Bioinformatics and system biology